In the stage I/II group, age, sex, race, marital status, tumor position, differentiation grade, T-stage, radiotherapy, chemotherapy, CEA, tumor deposits, number of examined regional lymph nodes and perineural invasion were significantly associated with cancer-specific survival (Table S2). This evidence concerns the gene CEACAM5 and cancer.